Peripheral Drug Eluting Stent System - India CDSCO Medical Device Registration

Peripheral Drug Eluting Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000086_45c357483978f9bc5cdb225296076384_bf4eb6f36306e39c5388994b7c275e0a. This device is marketed under the brand name TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM. The license holder is Relisys Medical Devices Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class D

Peripheral Drug Eluting Stent System

UID: MFG/MD/2020/000086_45c357483978f9bc5cdb225296076384_bf4eb6f36306e39c5388994b7c275e0a

Brand Name

TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM

License Holder

Relisys Medical Devices Limited

Device Class

Class D

Approving Authority

CDSCO, Zonal office, Hyderabad

Product Information

The Peripheral Drug-eluting Stent System is indicated for improving luminal diameter in the treatment of de novo or restenotic symptomatic lesion(TRICVALVE/ TREBLE/ TRICHOTOMIC/ TRIO/ TRICUSPIDEM) in native vascular disease of the above-the-knee femoropopliteal arteries with reference vessel diameter from 4.0 mm to 6.5 mm